Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson

Joshua J. Field, Gene Lin, Maureen M. Okam, Elaine Majerus, Jeffrey Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A<sub>2A</sub> receptor agonist regadenoson'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences